Clinical practice guidelines on newborn hearing screening: A systematic quality appraisal using the AGREE II

Kevin Chorath1, Luis Garza2, Aina Tarriela2

  • 1Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Most guidelines for newborn hearing loss detection and management are of average or low quality. This review highlights variability and aims to improve future guideline development and clinical selection.

Area of Science:

  • Audiology
  • Public Health
  • Evidence-Based Medicine

Background:

  • Numerous guidelines exist for newborn hearing loss screening and management.
  • The methodological quality of these protocols has not been previously assessed.

Purpose of the Study:

  • To identify and critically evaluate existing guidelines and consensus statements for neonatal hearing loss detection and management.

Main Methods:

  • A comprehensive literature search was conducted across major databases and grey literature.
  • The Appraisal of Guidelines for Research and Evaluation (AGREE II) tool was used by four independent reviewers.
  • Intraclass correlation coefficients (ICC) assessed inter-rater agreement.

Main Results:

  • Twelve guidelines were evaluated; only two were deemed 'high quality'.
  • The 'Scope and Purpose' domain scored highest (91.3%), while 'Rigor of Development' scored lowest (35.8%).
  • Good to very good inter-rater agreement was observed across all AGREE II domains (ICC 0.63-0.95).

Conclusions:

  • Significant variability exists in the methodological quality of guidelines for neonatal hearing loss.
  • Findings can inform improved reporting of future guidelines and aid clinical selection of existing ones.
Abstract